Evonik invests US$220 million in partnership with the U.S. Government to build new lipid production facility for mRNA-based therapies in the U.S. By Lucía Costa|2022-07-21T11:55:10+01:00June 2nd, 2022|Europe, FDI-News, North America, USA|0 Comments Read More